Interventional treatment for liver cancer, also known as minimally invasive surgical treatment for liver cancer, the main methods include tumor ablation, regional chemotherapy of hepatic artery or portal vein, and surgical types of hepatic artery chemoembolization, which is one aspect of the liver cancer treatment system and its therapeutic effect mainly depends on the indication. Minimally invasive surgery for hepatocellular carcinoma is generally used as a part of the whole treatment system, which has the advantages of simplicity, small trauma and fast recovery, and has quite good clinical effects. However, cancer treatment is a complete system, and minimally invasive surgery is only one of the parts, which also needs to be combined with radiotherapy, chemotherapy and regular follow-up for recurrence prevention to play an effect in the overall treatment. Minimally invasive surgery for liver cancer is not a panacea and has many prerequisite restrictions. Minimally invasive surgery is only applicable to patients without metastasis or palliative treatment for patients who cannot tolerate surgery at advanced stage. Overall, it is an adjuvant treatment means, aiming at prolonging life span or preparing for other surgeries, and it is only effective for patients who meet the indications, while patients who do not meet the indications can do nothing. Therefore, interventional treatment or minimally invasive surgery for liver cancer is part of the whole treatment system, which has certain advantages for patients who meet the indications, but can do nothing for other patients, and it is unrealistic to think that minimally invasive surgery alone can cure liver cancer.